Clinical trial for Type 2 Diabetes
Official title Pancreatic Insulin Production Capacity (PIPC) - a Feasibility Study
ClinicalTrials.gov ID: NCT06462170
What this study is testing
- What it's testing
- The study will measure insulin and blood sugar levels over two hours to learn why people with type 2 diabetes produce different amounts of insulin.
- Who it's for
- Adults who have type 2 diabetes.
- What's involved
- Participants will drink a meal‑replacement shake and have blood drawn five times over two hours to test insulin and glucose levels.
- Time commitment
- The study lasts about two hours with five blood draws during that time.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Consent provided
- Age \>= 18 years.
- Diagnosed as type 2 diabetes mellitus.
- Not on insulin therapy.
You likely can't join if
- Diagnosed as another form of diabetes mellitus.
- Allergic to one or more ingredients in Boost meal replacement shake.
- Unable to fast since midnight and attend in person for the morning protocol.
The study team makes the final eligibility decision.
Where it is enrolling
- Ottawa, Ontario, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Ottawa, Ontario, Canada. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.